Feature

COPD Clinical Trials at Temple Lung Center

Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity, and many patients continue to experience symptoms despite optimal therapy. As one of the world’s largest and most experienced COPD research programs, the Temple Lung Center offers access to clinical trials evaluating new pharmacologic, device-based, and comprehensive treatment approaches.

  • By

  • February 19, 2026

  • 2 min

Share

  • 1

    COPD is a leading cause of morbidity.

  • 2

    Temple Lung Center conducts innovative clinical trials.

  • 3

    Trials focus on pharmacologic and device-based therapies.

  • 4

    Multidisciplinary evaluations help match patients to trials.

  • 5

    Participation may provide access to emerging therapies.

  • 6

    Patients can inquire via email or phone.

  • 7

    Trials aim to enhance lung function and quality of life.

Original Source(s)

COPD Clinical Trials at Temple Lung Center

Chronic obstructive pulmonary disease (COPD) remains a major cause of morbidity, and many patients continue to experience symptoms despite optimal therapy. As one of the world’s largest and most experienced COPD research programs, the Temple Lung Center offers access to clinical trials evaluating new pharmacologic, device-based, and comprehensive treatment approaches.

  • by

  • February 19, 2026

  • 2 min

Related Content

Chronic Cough Despite Normal Workup

Researchers describe diagnostic evaluation and management considerations when standard testing fails to identify the cause of persistent cough.

2026 GOLD Report: A Landmark Revision Shaping the Future of COPD Management

  • by

  • December 21, 2025

  • 3 min
New Vaccine Prevents Severe RSV Illness

A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.